Important notice

The information contained in this section is intended only for the health professional authorised to prescribe or dispense medicinal products for which specialised training is required for proper interpretation. If you do not belong to this group, please refrain from continuing.

I declare I am a health professional with prescribing or dispensing capacity in Spain.

Septogin Spray

share, link, spread

50 ml spray

Septogin MD Spray is a product indicated for the treatment of gynecological exudative skin lesions.

Acting externally through direct topical application, zinc, copper and aluminium-potassium sulphates present in Septogin MD spray exert drying and astringent effects that eliminate exudate from exudative skin lesions. The reduction in the exudate of moist lesions with erythema, oedema, vesicles and/or secretion promotes healing of the skin. The anti-exudative effect reduces the risk of infection, relieves itching and eliminates unpleasant odours.

Septogin MD spray is suitable for use in young girls and pregnant women. Its formula is free from dyes or fragrance, pH neutral and compatible with other medicated treatments.

Indicated in the treatment of exudative gynaecological processes such as exudative vulvovaginitis, moist ‑exural dermatitis (submammary, inguinal, abdominal), intertrigo (submammary, inguinal), moist post-partum lesions (C-section incision in a fold, episiotomy dehiscence), exudative processes related to surgical procedures or to dry out genital herpes, among other things. Indicated to reduce the exudate of moist lesions with erythema, oedema, vesicles and/or secretion.

Promotes skin healing.

Reduces and prevents the risk of infection by pathogenic microbes.


Spray directly onto affected areas of the external genitalia 3 or 4 times. Repeat twice daily, preferably morning and night until the exudate or moisture disappears.

If desired, spray onto a gauze, cotton pad or compress until soaked in solution, and then apply to the affected area as a poultice for a few minutes, twice daily.


Our website uses our own cookies and those of third parties in order to customise browsing, and in order to improve your services by analysing the users surfing habits. By continuing to browse, you agree to use it in accordance with our Cookies Policy. AQUI

Required for technical reasons